Literature DB >> 25896212

Al adjuvants can be tracked in viable cells by lumogallion staining.

Irene Mile1, Andreas Svensson2, Anna Darabi3, Matthew Mold4, Peter Siesjö3, Håkan Eriksson5.   

Abstract

The mechanism behind the adjuvant effect of aluminum salts is poorly understood notwithstanding that aluminum salts have been used for decades in clinical vaccines. In an aqueous environment and at a nearly neutral pH, the aluminum salts form particulate aggregates, and one plausible explanation of the lack of information regarding the mechanisms could be the absence of an efficient method of tracking phagocytosed aluminum adjuvants and thereby the intracellular location of the adjuvant. In this paper, we want to report upon the use of lumogallion staining enabling the detection of phagocytosed aluminum adjuvants inside viable cells. Including micromolar concentrations of lumogallion in the culture medium resulted in a strong fluorescence signal from cells that had phagocytosed the aluminum adjuvant. The fluorescence appeared as spots in the cytoplasm and by confocal microscopy and co-staining with probes presenting fluorescence in the far-red region of the spectrum, aluminum adjuvants could to a certain extent be identified as localized in acidic vesicles, i.e., lysosomes. Staining and detection of intracellular aluminum adjuvants was achieved not only by diffusion of lumogallion into the cytoplasm, thereby highlighting the presence of the adjuvant, but also by pre-staining the aluminum adjuvant prior to incubation with cells. Pre-staining of aluminum adjuvants resulted in bright fluorescent particulate aggregates that remained fluorescent for weeks and with only a minor reduction of fluorescence upon extensive washing or incubation with cells. Both aluminum oxyhydroxide and aluminum hydroxyphosphate, two of the most commonly used aluminum adjuvants in clinical vaccines, could be pre-stained with lumogallion and were easily tracked intracellularly after incubation with phagocytosing cells. Staining of viable cells using lumogallion will be a useful method in investigations of the mechanisms behind aluminum adjuvants' differentiation of antigen-presenting cells into inflammatory cells. Information will be gained regarding the phagosomal pathways and the events inside the phagosomes, and thereby the ultimate fate of phagocytosed aluminum adjuvants could be resolved.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aluminum adjuvant; Flow cytometry; Lumogallion; Phagolysosome

Mesh:

Substances:

Year:  2015        PMID: 25896212     DOI: 10.1016/j.jim.2015.04.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Intracellular tracing of amyloid vaccines through direct fluorescent labelling.

Authors:  Matthew Mold; Manpreet Kumar; Ambreen Mirza; Emma Shardlow; Christopher Exley
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

2.  Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants.

Authors:  Andreas Svensson; Tove Sandberg; Peter Siesjö; Håkan Eriksson
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

3.  Aluminum hydroxide adjuvant diverts the uptake and trafficking of genetically detoxified pertussis toxin to lysosomes in macrophages.

Authors:  Javier Jaldin-Fincati; Serene Moussaoui; Maria Cecilia Gimenez; Cheuk Y Ho; Charlene E Lancaster; Roberto Botelho; Fernando Ausar; Roger Brookes; Mauricio Terebiznik
Journal:  Mol Microbiol       Date:  2022-04-07       Impact factor: 3.979

4.  Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.

Authors:  Matthew Mold; Emma Shardlow; Christopher Exley
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

5.  Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8+ T Cell Responses.

Authors:  Hao Jiang; Qin Wang; Lin Li; Qin Zeng; Hanmei Li; Tao Gong; Zhirong Zhang; Xun Sun
Journal:  Adv Sci (Weinh)       Date:  2017-11-09       Impact factor: 16.806

Review 6.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.